FreMon Scientific
FreMon Scientific is a medical device company that develops and manufactures the ZipThaw dry thawing system and ZipSleeve disposable consumables for hospitals, blood banks, cell and gene therapy labs, military medical facilities, and veterinary clinics.
- Company typePrivate
- Founded2017
- HeadquartersLa Jolla, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What FreMon Scientific does
FreMon Scientific, Inc. is a Delaware-incorporated medical device company headquartered in San Diego, California, that develops and manufactures the ZipThaw dry thawing system and its companion ZipSleeve disposable sleeve. Founded in 2017 by Frederick J. Thacher and Moni Shavit, the company targets the thawing of frozen blood products, plasma, and cell therapy materials as an alternative to traditional water baths, which carry contamination, maintenance, and footprint drawbacks. The ZipThaw202 device uses patented heating elements and multiple sensors to monitor actual product temperature in real time, with dual thawing chambers, a touch screen interface, and USB/ethernet data export; the ZipSleeve is a leak-proof disposable that conforms to most plasma unit sizes and is replaced after eight uses, with shelf life extended to seven years as of February 2026.
The company's revenue model combines one-time ZipThaw hardware sales with recurring ZipSleeve consumable sales, primarily through North American distributor Genesis BPS and an international distributor network spanning Israel, the UK, Turkey, the EU, the Middle East, China, Singapore, and South Africa. Pricing is quote-based and not publicly listed; the company uses multi-year contracts for devices and pay-as-you-go purchasing for consumables, supported by promotional mechanics such as 'Buy 4 packs, get 1 free' on ZipSleeves and historical year-end discounts of up to 30%. End customers include blood banks, hospitals, cell and gene therapy labs, military medical facilities, and veterinary clinics, with named accounts spanning MD Anderson Cancer Center, multiple US Armed Forces deployments, San Diego Blood Bank, AdventHealth, MedStar Georgetown University Hospital, and Disney's Animal Kingdom. Manufacturing of the ZipThaw device is performed by Minnetronix in St. Paul, Minnesota, while design engineering support is provided by Aran R&D in Israel. Under the leadership of CEO Dr. David P. Wellis and COO Andrew Wolf (appointed in 2024), the company now operates with 200+ installation locations across more than a dozen market segments.
FreMon holds a deep regulatory and intellectual property moat, including FDA 510(k) Class II clearance, CE Mark (valid through March 31, 2027), ISO 13485:2016 (valid through January 31, 2028), AABB Standards-Compliant designation (noted as the only such device registered with AABB), UL certification, and US Government MDERA cyber security certification. Three patents have been filed in seven major global markets covering more than 40 countries, with the ZipThaw and ZipSleeve trademarks registered. Validation partnerships with the New York Blood Center, San Diego Blood Bank, MedStar Georgetown, the US Army Institute of Surgical Research, and Comprehensive Cell Solutions (New York Blood Center Enterprises) provide published performance evidence — including 2% higher post-thaw cell viability, 1.39% hemolysis vs 2.02% for water baths, and 18% mean TAT concentration increase — that has been incorporated into the FDA submission and is used in the company's enterprise sales motion at trade shows such as AABB, ISCT, MHSRS, and IVECCS.
FreMon Scientific firmographics
Firmographics- Name
- FreMon Scientific
- Legal name
- FreMon Scientific, Inc.
- Website
- https://fremonscientific.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- FreMon Scientific is a medical device company that develops and manufactures the ZipThaw dry thawing system and ZipSleeve disposable consumables for hospitals, blood banks, cell and gene therapy labs, military medical facilities, and veterinary clinics.
- Ownership category
- akta.pro rank
Where FreMon Scientific is headquartered
LocationHeadquarters
- HQ city
- La Jolla
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
FreMon Scientific business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Others
Revenue model
- ZipThaw Device Sales: Sale of the ZipThaw202 thawing device - a dry, portable medical device for thawing blood products, plasma, and biologics. One-time hardware purchase.
- ZipSleeve Consumables: Recurring sales of ZipSleeve disposable smart sleeves used with ZipThaw. Each sleeve replaced after 8 uses or if plasma bag ruptures. 10-pack units.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | ZipThaw Device - Quote based pricing |
| Unit Pricing | Pay-as-you-go | ZipSleeve 10-packs |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
FreMon Scientific product offering
Product offeringCore offering
FreMon Scientific manufactures and sells the ZipThaw202, a portable dry thawing medical device for blood products, plasma, and biologics, along with its companion ZipSleeve disposable smart sleeve consumable. The ZipThaw system uses patented heating elements with multiple sensors that monitor actual product temperature in real-time during thawing, replacing traditional water baths used in blood banks, hospitals, cell and gene therapy labs, US military medical facilities, and veterinary clinics. ZipSleeve is a disposable leak-proof sleeve replaced after 8 uses that protects biologics from cross-contamination and conforms to nearly any plasma unit size.
Product overview
FreMon Scientific offers a product platform centered on the ZipThaw dry thawing device and its companion ZipSleeve disposable component. ZipThaw serves as the core device — a portable, dual-chamber medical instrument that precisely thaws frozen blood products, plasma, and cell therapy materials without water baths. ZipSleeve is the single-use (8 uses before replacement) smart sleeve that holds the biologic during thawing, enabling temperature monitoring and contamination protection. Together, they form an integrated thawing system for blood banks, hospitals, cell and gene therapy labs, bioproduction facilities, the military, and veterinary clinics.
Differentiator
Problem solved
Functional benefit
Brands
- ZipThaw: Dry, portable rapid plasma thawing medical device - FDA cleared, CE marked, AABB compliant blood product thawing system
- ZipSleeve
Products and services
- ZipThaw (ZipThaw202) ZipThaw is a dry, portable, rapid plasma and biologics thawing medical device that monitors actual product temperature during thawing via multiple sensors. It is FDA 510(k) cleared as a Class II medical device and replaces traditional water baths with a small-footprint device requiring minimal maintenance, featuring dual thawing chambers and real-time temperature display on a touch screen interface. The device is used by hospital blood banks, cell and gene therapy labs, US military medical facilities, and veterinary clinics for thawing frozen blood products, plasma, and biologics.
- ZipSleeve ZipSleeve is a patented disposable leak-proof smart sleeve used with the ZipThaw device to protect biologics from cross-contamination during thawing. It is a multi-use sleeve (replaced after 8 uses or if plasma bag ruptures) that enables rapid thawing and temperature monitoring, conforms to various plasma unit sizes, and is sold in 10-pack units as a recurring consumable. Shelf life was extended to 7 years as of February 2026.
Quantifiable outcome
- Post-thaw cell viability approximately 2% higher with ZipThaw vs water baths
- +7 more outcomes
Companies that use FreMon Scientific
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles4 records
FreMon Scientific technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
FreMon Scientific partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- Genesis BPScoreNorth America distributor for ZipThaw and ZipSleeve products. Handles purchase orders, promotions (such as buy 4 get 1 free ZipSleeve offers), and trade show presence at industry events like ISCT.
- Comprehensive Cell Solutions (CCS)coreDivision of New York Blood Center Enterprises conducting comparative assessment of ZipThaw versus traditional thawers for cryopreserved cell therapy starting material. Includes published validation studies.
- MedStar Georgetown University HospitalcoreSponsored Validation Study Agreement with Cell Therapy Manufacturing Facility to validate ZipThaw performance for off-label use in cell and gene therapy. Dr. Wanxing Cui presented findings at ISCT.
- MinnetronixcoreManufacturing partner in St. Paul, MN responsible for production and shipments of ZipThaw devices.
- Aran R&DcorePublicly traded engineering firm in Caesarea, Israel contracted for manufacturing engineering of ZipThaw and ZipSleeve. Conducted design review and prototype development.
- Baker TillyminorAccounting firm providing audit, tax and review services.
- Procopio LLPminorLaw firm providing corporate legal services and support.
- Thacher InteractiveminorMarketing agency providing print, digital, and social marketing services.
- New York Blood CentercoreConducted 14 days of testing over 3 months on ZipThaw and ZipSleeve prototypes. Test results included in FDA 510(k) application.
- San Diego Blood BankcoreServed as regional training center, conducted usability testing, and provided guidance on ZipThaw development. VP William Davey led blood bank operations involvement.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
FreMon Scientific competitors and assessment
Company assessmentDirect peers
- Helmer Scientific: Helmer Scientific is a direct competitor producing plasma thawing devices and other blood bank cold-chain equipment for hospitals and transfusion services. Their products are installed in many of the same US hospital blood banks that FreMon targets, making them the closest head-to-head competitor.
- Barkey (Azenta Life Sciences): Barkey, acquired by Azenta (formerly Brooks Life Sciences), manufactures dry plasma and blood thawing devices widely used in European hospitals and blood banks. It is the most direct international competitor to ZipThaw in the dry-thaw category, serving the same customer types with comparable hardware.
- ThermoGenesis (Cesca Therapeutics): ThermoGenesis, where FreMon co-founder Moni Shavit was VP of R&D, developed automated cell processing and cryopreservation systems for cord blood and cell therapy. It is a historical direct peer in automated blood/cell processing, with overlapping customer types in blood banks and cell therapy labs.
Emerging players
- MedCision (defunct, technology acquired): MedCision developed the ThawSTAR automated cell thawing system used in cell and gene therapy manufacturing. Its technology was acquired by Helmer, reinforcing Helmer's positioning as a direct competitor; MedCision pioneered the same dry-thaw paradigm for cryopreserved cell therapy starting material that FreMon is pursuing.
- BioLife Solutions: BioLife Solutions provides biopreservation media (CryoStor, HypoThermosol) and custom cold-chain solutions for cell and gene therapy. While it is not a thawing device maker, it serves the same cryopreserved cell therapy workflow customers and represents an adjacent consumable partner or competitor for cell therapy thawing workflows.
- Vineti: Vineti provides a cell therapy orchestration and chain-of-custody software platform used by advanced therapy manufacturers. It is adjacent to FreMon's cell therapy thawing use case and would be a relevant partner or comparability reference for cell and gene therapy commercialization workflows.
Broad incumbents
- Terumo BCT: Terumo BCT is a global leader in blood component processing, including apheresis and whole blood separation systems used by blood centers. William Davey, FreMon's VP of Product, is a former TerumoBCT Global Product Manager, and Terumo BCT serves the same blood banking customers with adjacent capital equipment.
- Cytiva (Danaher): Cytiva is a large bioprocessing and cell therapy equipment supplier owned by Danaher, offering instruments, consumables, and software for cell and gene therapy manufacturing. It targets the same cell and gene therapy labs FreMon is pursuing and represents a broad incumbent alternative for cryopreserved product handling.
- Sartorius AG: Sartorius is a large bioprocess and cell therapy equipment supplier with a portfolio spanning upstream and downstream cell processing. It serves the same cell and gene therapy manufacturing customers that FreMon targets with ZipThaw for off-label cryopreserved product thawing.
Others
- Saint-Gobain Life Sciences: Saint-Gobain Life Sciences supplies single-use bioprocess components and fluid management products to cell therapy and biopharma manufacturers. It is an enabling/supplier-side peer in the cell and gene therapy cold chain that FreMon is increasingly participating in.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
FreMon Scientific social profiles
Digital presenceFreMon Scientific compliance and trust
Trust signalCompliance6 records
FreMon Scientific financial estimates
Financial estimateRevenue estimate
Valuation estimate
FreMon Scientific leadership team
Management profileNumber of profiles
Profiles6 records
FreMon Scientific funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FreMon Scientific M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FreMon Scientific
What does FreMon Scientific do?
FreMon Scientific manufactures and sells the ZipThaw202, a portable dry thawing medical device for blood products, plasma, and biologics, along with its companion ZipSleeve disposable smart sleeve consumable. The ZipThaw system uses patented heating elements with multiple sensors that monitor actual product temperature in real-time during thawing, replacing traditional water baths used in blood banks, hospitals, cell and gene therapy labs, US military medical facilities, and veterinary clinics. ZipSleeve is a disposable leak-proof sleeve replaced after 8 uses that protects biologics from cross-contamination and conforms to nearly any plasma unit size.
Is FreMon Scientific a public or private company?
FreMon Scientific is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was FreMon Scientific founded?
FreMon Scientific was founded in 2017. It employs 1 to 10 people.
Where is FreMon Scientific based?
FreMon Scientific is headquartered in La Jolla, United States, in the North America region.
How does FreMon Scientific make money?
Two revenue lines are on record. ZipThaw Device Sales are the primary driver. The others are zipSleeve Consumables.
Who are FreMon Scientific's main competitors?
Direct peers on record are Helmer Scientific, Barkey (Azenta Life Sciences) and ThermoGenesis (Cesca Therapeutics). Emerging players are MedCision (defunct, technology acquired), BioLife Solutions and Vineti. Broad incumbents are Terumo BCT, Cytiva (Danaher) and Sartorius AG. Saint-Gobain Life Sciences is listed as an others.
Does FreMon Scientific have an API?
No public API is recorded for FreMon Scientific.